The rise of generative AI (GenAI) is transforming how life sciences organizations approach evidence synthesis, regulatory submissions, and market access activities. As literature review workflows become more complex—and timelines more compressed—life science professionals are increasingly turning to GenAI-enabled platforms to streamline systematic literature reviews (SLRs), reduce manual burden, and scale evidence synthesis.
However, evaluating…
As the demands for faster, more accurate, and scalable literature reviews rise in life sciences, AI is no longer just a future promise—it’s a proven performance driver. Systematic literature review (SLR) teams, especially in HEOR and medical affairs, are adopting GenAI platforms not just for experimentation but to solve long-standing bottlenecks in screening, extraction, and…
The promise of Artificial Intelligence (AI) in life sciences is undeniable—offering advancements in drug discovery, clinical research, and evidence generation. Yet, many organizations still struggle to implement AI effectively. To better understand these challenges, CapeStart conducted a survey of 104 life science professionals, asking them: What are the top three barriers to success for your…
Artificial Intelligence (AI) holds immense promise, but its successful adoption depends on two critical factors: whether teams have the capability to implement AI strategies and whether they can access the right vendor support. CapeStart’s Life Science AI Research Report sheds light on these questions, offering a deeper understanding of how organizations are navigating these challenges.
Team…
Artificial Intelligence (AI) is no longer a concept of the future—it's firmly entrenched in the here and now. CapeStart’s Life Science AI Research Report examines how actively life science professionals involved in AI initiatives. The findings underscore how AI is gradually transforming businesses, particularly in the life sciences industry.
Engagement in AI Initiatives: A Snapshot…
Artificial Intelligence (AI) is making waves in industries worldwide, but how do professionals in life sciences feel about its potential? According to CapeStart’s Life Science AI Research Report, a resounding 91% of respondents believe that AI can assist and empower their work. This overwhelming optimism highlights a strong recognition of AI’s transformative capabilities. Belief in…
